Translation of Pre-Clinical Studies into Successful Clinical Trials for Alzheimer's Disease: What are the Roadblocks and How Can They Be Overcome? (Q38592069)

From Wikidata

Jump to navigation Jump to search

scientific article published on August 2015

Language	Label	Description	Also known as
English	Translation of Pre-Clinical Studies into Successful Clinical Trials for Alzheimer's Disease: What are the Roadblocks and How Can They Be Overcome?	scientific article published on August 2015

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26401762%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Translation of Pre-Clinical Studies into Successful Clinical Trials for Alzheimer's Disease: What are the Roadblocks and How Can They Be Overcome? (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26401762%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Alzheimer's disease

0 references

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26401762%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26401762%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

M. V. Padma Srivastava

14

object named as

M V Padma Srivastava

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26401762%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Dheeraj Khurana

5

object named as

Dheeraj Khurana

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26401762%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

Avijit Banik

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26401762%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Richard E Brown

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26401762%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

James Bamburg

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26401762%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Debomoy K Lahiri

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26401762%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Robert P Friedland

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26401762%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Wei Chen

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26401762%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Amritpal Mudher

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26401762%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Ante L Padjen

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26401762%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Elizabeta Mukaetova-Ladinska

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26401762%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Sudhir Srivastava

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26401762%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Raj N Kalaria

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26401762%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Akshay Anand

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26401762%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Colin L Masters

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26401762%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

publication date

1 January 2015

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26401762%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Journal of Alzheimer's Disease

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26401762%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

47

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26401762%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

815-843

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26401762%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26401762%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Epidemiology of Alzheimer disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

The global prevalence of dementia: a systematic review and metaanalysis

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Central Challenges Facing the National Clinical Research Enterprise

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

The meaning of translational research and why it matters

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Fire in the ashes: can failed Alzheimer's disease drugs succeed with second chances?

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Bacopa monniera ameliorates amnesic effects of diazepam qualifying behavioral-molecular partitioning

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Scopolamine induced amnesia is reversed by Bacopa monniera through participation of kinase-CREB pathway

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Antiamnesic effect of B. monniera on L-NNA induced amnesia involves calmodulin

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Traditional Chinese medicine: a promising candidate for the treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

The acute effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy normal subjects.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

An acute, double-blind, placebo-controlled crossover study of 320 mg and 640 mg doses of a special extract of Bacopa monnieri (CDRI 08) on sustained cognitive performance

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Oxidative insults to neurons and synapse are prevented by aged garlic extract and S-allyl-L-cysteine treatment in the neuronal culture and APP-Tg mouse model

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Herbal medicine in the United States: review of efficacy, safety, and regulation: grand rounds at University of California, San Francisco Medical Center

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Removing obstacles in neuroscience drug discovery: the future path for animal models

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Can animal models of disease reliably inform human studies?

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

The animal models of dementia and Alzheimer's disease for pre-clinical testing and clinical translation

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Transplantation of primed human fetal neural stem cells improves cognitive function in rats after traumatic brain injury

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Embryonic stem cell-derived neural precursor cells improve memory dysfunction in Abeta(1-40) injured rats

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

The plasma membrane redox system is impaired by amyloid β-peptide and in the hippocampus and cerebral cortex of 3xTgAD mice.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Selecting a mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studies

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Alzheimer's disease genetics: lessons to improve disease modelling

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

The impact of cerebrospinal fluid biomarkers on the diagnosis of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

The future of blood-based biomarkers for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Plasma biomarkers for Alzheimer's disease: much needed but tough to find

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

The application of cerebrospinal fluid biomarkers in early diagnosis of Alzheimer disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Cognitive correlates of cerebrospinal fluid biomarkers in frontotemporal dementia

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Overlapping profiles of Aβ peptides in the Alzheimer's disease and pathological aging brains.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Supporting evidence for using biomarkers in the diagnosis of MCI due to AD.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Biomarkers for the clinical evaluation of the cognitively impaired elderly: amyloid is not enough

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Alzheimer's disease biomarker discovery using in silico literature mining and clinical validation

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Impact of ¹⁸F-florbetapir PET imaging of β-amyloid neuritic plaque density on clinical decision-making

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Imaging epigenetics in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Epigenetic regulation of BACE1 in Alzheimer's disease patients and in transgenic mice.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Brain imaging in the study of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Evidence for ordering of Alzheimer disease biomarkers

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Longitudinal change of biomarkers in cognitive decline

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Update on the pharmacological treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Criteria for the neuropathological diagnosis of dementing disorders: routes out of the swamp?

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

'Clinical trials in Alzheimer's disease': immunotherapy approaches

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Tau-targeted treatment strategies in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Developing novel immunogens for a safe and effective Alzheimer's disease vaccine

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Alzheimer disease: Lessons from immunotherapy for Alzheimer disease.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Pharmacological study on Alzheimer's drugs targeting calcium/calmodulin-dependent protein kinase II.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Microtubule stabilizing agents as potential treatment for Alzheimer's disease and related neurodegenerative tauopathies

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Pathogenesis and disease-modifying therapy in Alzheimer's disease: the flat line of progress

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Metal ionophore treatment restores dendritic spine density and synaptic protein levels in a mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Toward the treatment and prevention of Alzheimer's disease: rational strategies and recent progress

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Effectiveness of antidementia drugs in delaying Alzheimer's disease progression.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Alzheimer's disease drug development and the problem of the blood-brain barrier

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Drug delivery strategies for Alzheimer's disease treatment.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Blood-brain barrier pathology in Alzheimer's and Parkinson's disease: implications for drug therapy

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Intranasal administration of TAT-haFGF(₁₄₋₁₅₄) attenuates disease progression in a mouse model of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Intracerebroventricular administration of drugs

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

First clinical data of the neuroprotective effects of nasal insulin application in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

A novel approach for long-term oral drug administration in animal research

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Quantification of Alzheimer pathology in ageing and dementia: age-related accumulation of amyloid-beta(42) peptide in vascular dementia.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Cell biology. A unifying role for prions in neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

The presence of sodium dodecyl sulphate-stable Abeta dimers is strongly associated with Alzheimer-type dementia.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Metal binding modes of Alzheimer's amyloid beta-peptide in insoluble aggregates and soluble complexes.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Affinity of Cu+ for the copper-binding domain of the amyloid-β peptide of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Copper depletion down-regulates expression of the Alzheimer's disease amyloid-beta precursor protein gene

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Oxidative stress in the progression of Alzheimer disease in the frontal cortex

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Neuropathologic studies of the Baltimore Longitudinal Study of Aging (BLSA)

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Amyloid beta and the longest-lived rodent: the naked mole-rat as a model for natural protection from Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Neuroscience. Promiscuous Alzheimer's amyloid: yet another partner

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Quantification of the binding properties of Cu2+ to the amyloid beta peptide: coordination spheres for human and rat peptides and implication on Cu2+-induced aggregation

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Human LilrB2 is a β-amyloid receptor and its murine homolog PirB regulates synaptic plasticity in an Alzheimer's model

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer aβ oligomer bound to cellular prion protein

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Normal cognition in transgenic BRI2-Aβ mice

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Beyond amyloid: the next generation of Alzheimer's disease therapeutics.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Beyond amyloid: getting real about nonamyloid targets in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Neurodegenerative stimuli induce persistent ADF/cofilin-actin rods that disrupt distal neurite function

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Neuroinflammatory phenotype in early Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Isolation and characterization of cytoplasmic cofilin-actin rods

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Incorporation of cofilin into rods depends on disulfide intermolecular bonds: implications for actin regulation and neurodegenerative disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Beta-secretase-cleaved amyloid precursor protein accumulates at actin inclusions induced in neurons by stress or amyloid beta: a feedforward mechanism for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

MicroRNA-related cofilin abnormality in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Cofilin aggregation blocks intracellular trafficking and induces synaptic loss in hippocampal neurons

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

ADF/cofilin-mediated actin dynamics regulate AMPA receptor trafficking during synaptic plasticity

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Amyloid beta dimers/trimers potently induce cofilin-actin rods that are inhibited by maintaining cofilin-phosphorylation

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Cofilin-mediated neurodegeneration in Alzheimer's disease and other amyloidopathies

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Amyloid-β and proinflammatory cytokines utilize a prion protein-dependent pathway to activate NADPH oxidase and induce cofilin-actin rods in hippocampal neurons

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Animal models in the drug discovery pipeline for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Drosophila as a model to study age-related neurodegenerative disorders: Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson's disease, Alzheimer's disease and autism spectrum disorder

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Zebrafish as a tool in Alzheimer's disease research.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Mouse models of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

The rat as an animal model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Nonhuman primate models of Alzheimer-like cerebral proteopathy

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Cerebral amyloid β(42) deposits and microvascular pathology in ageing baboons

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

The value and limitations of transgenic mouse models used in drug discovery for Alzheimer's disease: an update

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Animal models of Alzheimer disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Targeting phospho-Ser422 by active Tau Immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

The relevance of individual genetic background and its role in animal models of epilepsy

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

What are we measuring when we test strain differences in anxiety in mice?

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Strain and sex differences in anxiety-like and social behaviors in C57BL/6J and BALB/cJ mice.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Sex differences in the brain: the not so inconvenient truth

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Sex difference in pathology and memory decline in rTg4510 mouse model of tauopathy.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Social stress in mice: gender differences and effects of estrous cycle and social dominance.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Sex bias in neuroscience and biomedical research

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Sexual dimorphism in healthy aging and mild cognitive impairment: a DTI study

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Similarities and differences in genome-wide expression data of six organisms

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Dose translation from animal to human studies revisited

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Global similarity and local divergence in human and mouse gene co-expression networks

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Divergence of human and mouse brain transcriptome highlights Alzheimer disease pathways

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Dynamic changes in myelin aberrations and oligodendrocyte generation in chronic amyloidosis in mice and men.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Large scale comparison of global gene expression patterns in human and mouse.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

A cross-species analysis method to analyze animal models' similarity to human's disease state

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Neuron-Enriched Gene Expression Patterns are Regionally Anti-Correlated with Oligodendrocyte-Enriched Patterns in the Adult Mouse and Human Brain

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Neuropathology of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

The levels of water-soluble and triton-soluble Aβ are increased in Alzheimer's disease brain

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

A mouse model of amyloid beta oligomers: their contribution to synaptic alteration, abnormal tau phosphorylation, glial activation, and neuronal loss in vivo.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Recent rodent models for Alzheimer's disease: clinical implications and basic research

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Plaques, tangles, and memory loss in mouse models of neurodegeneration.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Alzheimer disease models and human neuropathology: similarities and differences

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Interaction between NH(2)-tau fragment and Aβ in Alzheimer's disease mitochondria contributes to the synaptic deterioration

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Epidemiological of and risk factors for Alzheimer's disease: a review

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

What does the pediatrician need to know about Alzheimer disease?

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Traumatic brain injury: a risk factor for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Brain aging and late-onset Alzheimer's disease: many open questions

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Lifestyle behavior pattern is associated with different levels of risk for incident dementia and Alzheimer's disease: the Cache County study

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

The projected effect of risk factor reduction on Alzheimer's disease prevalence

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Acceleration of brain amyloidosis in an Alzheimer's disease mouse model by a folate, vitamin B6 and B12-deficient diet

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

A mouse model characterizing features of vascular dementia with hippocampal atrophy

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Pathological synergism between amyloid-beta and apolipoprotein E4--the most prevalent yet understudied genetic risk factor for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

The genetics of the human APOE polymorphism

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Mechanisms underlying insulin deficiency-induced acceleration of β-amyloidosis in a mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Are certain lifestyle habits associated with lower Alzheimer's disease risk?

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Exercise is more effective than diet control in preventing high fat diet-induced β-amyloid deposition and memory deficit in amyloid precursor protein transgenic mice

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Vascular risk factors and neurodegeneration in ageing related dementias: Alzheimer's disease and vascular dementia

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

An active and socially integrated lifestyle in late life might protect against dementia

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Life style interventions to reduce the risk of dementia

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Prevention in psychiatry: effects of healthy lifestyle on cognition.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

The fetal basis of amyloidogenesis: exposure to lead and latent overexpression of amyloid precursor protein and beta-amyloid in the aging brain.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

The LEARn model: an epigenetic explanation for idiopathic neurobiological diseases.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Do early-life insults contribute to the late-life development of Parkinson and Alzheimer diseases?

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Applying epigenetics to Alzheimer's disease via the latent early-life associated regulation (LEARn) model.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Alzheimer's disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Regulatory innovation and drug development for early-stage Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Clinical and research diagnostic criteria for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Improving animal models for nervous system disorders.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Visual detection, pattern discrimination and visual acuity in 14 strains of mice.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Age-related changes in visual acuity, learning and memory in C57BL/6J and DBA/2J mice.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

A phenotypic and molecular characterization of the fmr1-tm1Cgr fragile X mouse.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Detecting spatial memory deficits beyond blindness in tg2576 Alzheimer mice.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Loss of learning in mice when exposed to rat odor: a water maze study.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

The lonely mouse: verification of a separation-induced model of depression in female mice

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

The effects of apparatus design and test procedure on learning and memory performance of C57BL/6J mice on the Barnes maze.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Optimization of apparatus design and behavioral measures for the assessment of visuo-spatial learning and memory of mice on the Barnes maze.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

A call for transparent reporting to optimize the predictive value of preclinical research

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Publication bias in reports of animal stroke studies leads to major overstatement of efficacy

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Publication bias in laboratory animal research: a survey on magnitude, drivers, consequences and potential solutions

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Neuroprotection for ischaemic stroke: translation from the bench to the bedside

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Survey of the quality of experimental design, statistical analysis and reporting of research using animals

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Statistical design considerations in animal studies published recently in cancer research.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Better reporting of randomised controlled trials: the CONSORT statement

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Standards for the publication of mouse mutant studies

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

The role of monitoring interpretive rates, concordance between cytotechnologist and pathologist interpretations before sign-out, and turnaround time in gynecologic cytology quality assurance: findings from the College of American Pathologists Gyneco

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Genome-wide association studies in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Genetics of familial and sporadic Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Genetics and epigenetics of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

SNP association studies in Alzheimer's disease highlight problems for complex disease analysis.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Finding the missing heritability of complex diseases

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Alzheimer's disease and environmental exposure to lead: the epidemiologic evidence and potential role of epigenetics

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Targeted proteomics for quantification of histone acetylation in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

The benefits of using genetic information to design prevention trials

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

How were new medicines discovered?

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Phenotypic vs. target-based drug discovery for first-in-class medicines

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Computational drug repositioning: from data to therapeutics

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Modern phenotypic drug discovery is a viable, neoclassic pharma strategy

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Statistical analysis, trial design and duration in Alzheimer's disease clinical trials: a review

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Putting the Alzheimer's cognitive test to the test II: Rasch Measurement Theory.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Do current therapeutic anti-Aβ antibodies for Alzheimer's disease engage the target?

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Revising the definition of Alzheimer's disease: a new lexicon.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Promoting interactions with basic scientists and clinicians: the NIA Alzheimer's Disease Data Coordinating Center

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Meeting report: The future of preclinical mouse models in melanoma treatment is now.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Innovative solutions to novel drug development in mental health

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

CNTRICS final animal model task selection: control of attention

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Validation of experimental medicine methods in psychiatry: the P1vital approach and experience

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

A strategy for developing new treatment paradigms for neuropsychiatric and neurocognitive symptoms in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

The National Alzheimer's Coordinating Center (NACC) database: the Uniform Data Set.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Mary S. Easton Center of Alzheimer's Disease Research at UCLA: advancing the therapeutic imperative

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Alzheimer's disease public-private partnerships: A landscape of the global nonprofit community

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Animal models of neurological disease: are there any babies in the bathwater?

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150136

21 January 2018

Identifiers

10.3233/JAD-150136

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26401762%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26401762%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38592069&oldid=1508049079"